camptothecin has been researched along with combretastatin a-4 disodium phosphate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baumann, M; Baxendale, IR; Broggini, G; Bucci, R; Calogero, F; Christodoulou, MS; Dalla Via, L; Dapiaggi, F; García-Argáez, AN; Gazzola, S; Lahtela-Kakkonen, M; Liekens, S; Martinet, N; Nonell-Canals, A; Passarella, D; Pieraccini, S; Santamaría-Navarro, E; Silvani, A; Sironi, M | 1 |
1 other study(ies) available for camptothecin and combretastatin a-4 disodium phosphate
Article | Year |
---|---|
Boehmeriasin A as new lead compound for the inhibition of topoisomerases and SIRT2.
Topics: Cell Line; Cell Proliferation; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HeLa Cells; Humans; Models, Molecular; Molecular Structure; Phenanthrenes; Quinolizidines; Sirtuin 2; Structure-Activity Relationship; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 2015 |